More in Business
Business
Amitabh Chaudhry needs to rethink Axis Mutual Fund’s revival strategy
The fund house has fallen behind its peers. What explains the sub-par performance?
You may also like
Business
Mankind needs to get its mojo back
Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.
Business
Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
